Strengthening the Health Systems Response to COVID-19 - Technical guidance #3, 6 April 2020 (produced by WHO/Europe)

Supply of essential medicines and health technologies

This document is for decision makers, policy makers and national or regional authorities tasked with ensuring the uninterrupted supply of medicines and health technologies during the COVID-19 outbreak. During the COVID-19 outbreak, regular supply chains of essential medicines and health technologies may be disrupted. Countries will want to procure the same products at the same time; therefore, ensuring sustainable access to medicines and health technologies during this period will be challenging. The document focuses guidance on the prioritization, legislation, registration and marketing authorization, procurement, distribution and management of shortages.